Macsita-MXR 50/500 Tablet
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Sitagliptin (50mg) + Metformin (500mg)
Overview Macsita-MXR 50/500 Tablet
Diabex-Duo 50/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like vision loss and kidney disease, potentially lowering the risk of stroke or heart attack. Diabex-Duo may be used independently or in conjunction with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual health, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; cessation requires physician approval. Adherence to the prescribed diet and exercise plan is crucial for diabetes control, as lifestyle significantly impacts management. Common side effects include nausea, vomiting, diarrhea, headache, stomach discomfort, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, especially when combined with insulin or sulfonylureas; learn its symptoms and management. This medication isn't for everyone. Inform your doctor of any history of liver, kidney, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or breastfeeding individuals should consult their doctor. Interactions with other medications are possible; disclose all medications to your doctor for safety. Alcohol should be limited due to its blood sugar-lowering effect. Your physician will monitor kidney function and blood glucose levels throughout treatment.
Uses of Macsita-MXR 50/500 Tablet
Managing type 2 diabetes
Major Benefits of Macsita-MXR 50/500 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Macsita-MXR 50/500 with a meal.
Common Side effects of Macsita-MXR 50/500 Tablet:
- Decreased appetite
- Vomiting
- Upper respiratory tract infection
- Hypoglycemia (low blood glucose level)
- Abdominal bloating
- Nausea
- Diarrhea
How to use Macsita-MXR 50/500 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Macsita-MXR 50/500 Tablets should be administered with a meal.
How Macsita-MXR 50/500 Tablet works:
Macsita-MXR 50/500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This dual action leads to improved glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Macsita-MXR 50/500 Tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Macsita-MXR 50/500 tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Macsita-MXR 50/500 tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Patients with kidney impairment should use Macsita-MXR 50/500 Tablets cautiously, potentially requiring dose modification. Consult your physician. Macsita-MXR 50/500 Tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverUNSAFE
The use of Macsita-MXR 50/500 tablets is likely contraindicated in individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Macsita-MXR 50/500 Tablet :
Should you forget to take your Macsita-MXR 50/500 Tablet, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Macsita-MXR 50/500 Tablet
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Diabetes Management |